The Pl Venlo, Netherlands-based company said it had profit of 42 cents per share. Earnings, adjusted for non-recurring costs, came to 51 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 45 cents per share.
The diagnostic products maker posted revenue of $515.5 million in the period, which also beat Street forecasts. Three analysts surveyed by Zacks expected $498.1 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on QGEN at https://www.zacks.com/ap/QGEN
